New York Mercantile Exchange › CRUDE OIL Oct 2014/Jun 2015 Spread (NYMEX:CL.V14_M15.E)
2.00 -0.26 (-13.00%)
2013-05-22 17:43:25, 30 min delay
| Last Price | 2.00 |
|---|---|
| Open | 2.00 |
| High | 2.00 |
| Time | 2013-05-22 17:43:25 |
| Contract High Date | 2013-04-02 |
| Contract Low Date | 2013-04-17 |
| Close Time | 17:15 |
| Settle Time | 17:43 |
|---|---|
| Previous Close | 2 |
| Low | 2.00 |
| Contract High | 2.43 |
| Contract Low | 1.04 |
| Open Time | 18:00 |
Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.
Trader's Blog
This is what I said on CNBC Asia before the crash
4 hours ago
Market sell-off goes on
4 hours ago
Investors Versus Traders: A Battle for Oil & Gas Profits
16 hours ago
Today's Video Update: Target And Lowe's Both Miss... Who's Next?
23 hours ago
Today's News
AP Top Extended Financial Headlines At 12:31 p.m. EDT
1 hour, 16 minutes ago
US stock prices ease, recovering most of an early swoon, after Chinese manufacturing contracts US new home sales rise 2.3 percent in April while median home prices hit record high
AP Top Financial News At 12:31 p.m. EDT
1 hour, 18 minutes ago
US stock market recovers most of an early loss US rate on 30-year mortgages rises to 3.59 pct. US new home sales up 2.3 percent in April
Advance Auto Parts' 1Q profit down nearly 9 pct
1 hour, 20 minutes ago
Advance Auto Parts Inc. said Thursday that its first-quarter profit fell nearly 9 percent as it experienced softer sales and higher costs. The results beat Wall Street expectations by three cents per share but the company tempered its full-year outlook. Its shares fell $2.10, or 2.5 percent, to $83.70 in midday trading.
Halozyme names David Ramsay as CFO
1 hour, 28 minutes ago
Biopharmaceutical company Halozyme Therapeutics Inc. said Thursday that it has named David Ramsay as chief financial officer, replacing Kurt Gustafson. Ramsay previously served as Halozyme's vice president of corporate development, but he joined the company in 2003 as CFO. Gustafson had been an executive at Amgen Inc. before he joined Halozyme in 2009. Halozyme said he was leaving the company to pursue other opportunities.
